Alveolar-like Macrophages Attenuate Respiratory Syncytial Virus Infection

Area of Science:

• Pulmonology
• Virology
• Stem Cell Biology
• Immunology

Background:

• Respiratory Syncytial Virus (RSV) is a major cause of severe respiratory illness in infants and young children.
• Current preventive strategies for RSV, including vaccines and monoclonal antibodies, have limitations in efficacy or accessibility.
• There is a critical need for novel approaches to prevent RSV infection and its associated long-term lung complications.

Purpose of the Study:

• To investigate the potential of pluripotent stem cell-derived alveolar-like macrophages (ALMs) as a novel strategy to prevent RSV infection.
• To elucidate the mechanisms by which ALMs confer protection against RSV.
• To evaluate the in vivo efficacy of ALMs in a murine model of RSV infection.

Main Methods:

• Generation of ALMs from pluripotent stem cells.
• Co-culture of ALMs with RSV-infected epithelial cells to assess antiviral effects.
• Analysis of RSV particle phagocytosis and soluble antiviral factor production by ALMs.
• Intratracheal administration of ALMs in mice followed by RSV challenge to evaluate in vivo protection.

Main Results:

• ALMs were not productively infected by RSV and effectively prevented RSV infection of epithelial cells.
• Protection was mediated by both phagocytosis of RSV particles and the release of a novel antiviral soluble factor.
• Intratracheal ALM administration in mice reduced weight loss, viral load, and lung inflammation post-RSV infection.

Conclusions:

• ALMs demonstrate significant potential as a prophylactic cell-based therapy against RSV infection.
• Stem cell-derived ALMs offer a promising new avenue for combating pulmonary viral infections in pediatric populations.
• Further research into ALM-based therapies is warranted for improving global pediatric respiratory health.